BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rhodes T, Lancaster K. Evidence-making hepatitis C cure: Towards a science that knows more carefully. Int J Drug Policy 2019;72:40-6. [PMID: 31307851 DOI: 10.1016/j.drugpo.2019.06.023] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Grebely J, Hajarizadeh B, Lazarus JV, Bruneau J, Treloar C; International Network on Hepatitis in Substance Users. Elimination of hepatitis C virus infection among people who use drugs: Ensuring equitable access to prevention, treatment, and care for all. Int J Drug Policy 2019;72:1-10. [PMID: 31345644 DOI: 10.1016/j.drugpo.2019.07.016] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
2 Sebeelo TB. "Undisciplined" drinking, multi-sectoralism and political power: Examining problematisations in the Botswana alcohol policy. Int J Drug Policy 2021;94:103228. [PMID: 33845411 DOI: 10.1016/j.drugpo.2021.103228] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Rhodes T, Lancaster K. How to think with models and targets: Hepatitis C elimination as a numbering performance. Int J Drug Policy 2021;88:102694. [PMID: 32245664 DOI: 10.1016/j.drugpo.2020.102694] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
4 Rance J, Rhodes T, Lancaster K. Pharmaceutical citizenship in an era of universal access to hepatitis C treatment: Situated potentials and limits. Health (London) 2021;:1363459320988887. [PMID: 33506718 DOI: 10.1177/1363459320988887] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Rhodes T, Lancaster K. Evidence-making interventions in health: A conceptual framing. Social Science & Medicine 2019;238:112488. [DOI: 10.1016/j.socscimed.2019.112488] [Cited by in Crossref: 47] [Cited by in F6Publishing: 34] [Article Influence: 15.7] [Reference Citation Analysis]
6 Lafferty L, Rance J, Grebely J, Dore GJ, Lloyd AR, Treloar C; SToP-C Study Group. Perceptions and concerns of hepatitis C reinfection following prison-wide treatment scale-up: Counterpublic health amid hepatitis C treatment as prevention efforts in the prison setting. Int J Drug Policy 2020;77:102693. [PMID: 32045828 DOI: 10.1016/j.drugpo.2020.102693] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]